CellBri Information

CellBri, known in China as Saiqiao Biotech, is redefining what's possible in cell therapy manufacturing solutions for cell therapies. We focus on developing automated, closed, digital, and regulatory-compliant systems for cell processing and fill-and-finish operations. Partnering with CellBri enables academic institutions, biotechnology firms, and pharmaceutical companies in the cell therapy field to accelerate drug development, enhance manufacturing capabilities, reduce process failures, lower production costs, and meet global patient needs. Founded in 2020 and built upon more than a decade of core technical expertise, CellBri was created with a simple vision: to make life-changing therapies more accessible by simplifying and scaling how they are made. Our flexible automation solutions support customers from early research and process development through commercial manufacturing, without requiring disruptive changes to existing workflows. Operating globally, CellBri is headquartered in Shenzhen, China, with additional locations across China, North American operations in Los Angeles, California, a U.S. Demo Lab in Carlsbad, California, a European Demo Lab in Barcelona, Spain, and European manufacturing capabilities in Hungary.